Syra Health (SYRA) Registration Filing summary

Company overview and business model

• Operates as a healthcare services provider focused on preventative health, holistic wellness, health education, and equitable care for diverse populations.

• Offers solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce, targeting payers, providers, life sciences, academia, and government.

• Launched Syrenity, an AI-driven mental health app, in Q4 2024 and is developing additional digital health platforms and analytics services.

• Growth strategy includes expanding geographically, investing in partnerships, and potential acquisitions to enhance service lines and market reach.

Financial performance and metrics

• Reported revenues of approximately $6.0 million for the nine months ended September 30, 2024, and $5.5 million and $5.6 million for the years ended December 31, 2023 and 2022, respectively.

• Future profitability is uncertain, and there is substantial doubt about the ability to continue as a going concern.

• Public float as of January 7, 2025, was $6,624,952 based on 8,964,753 shares held by non-affiliates at $0.739 per share.

Use of proceeds and capital allocation

• Net proceeds are intended for general corporate purposes, including sales and marketing, operational costs, product development, manufacturing expansion, working capital, and potential debt repayment or acquisitions.

• Management retains broad discretion over allocation of proceeds, with no specific commitments to investments or acquisitions as of the filing date.